Wilfred A. Jefferies
Fondateur chez MYND LIFE SCIENCES INC.
Fortune : 196 471 $ au Aujourd'hui
Postes actifs de Wilfred A. Jefferies
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| MYND LIFE SCIENCES INC. | Directeur/Membre du Conseil | - | - |
| Directeur Technique/Scientifique/R&D | 26/11/2020 | - | |
| Fondateur | 06/07/2018 | - | |
| Président | 26/11/2020 | 04/12/2023 | |
| University of British Columbia | Corporate Officer/Principal | - | - |
Michael Smith Laboratories
 Michael Smith Laboratories Miscellaneous Commercial ServicesCommercial Services Michael Smith Laboratories provides biotechnology research and training services. It investigates genetics in human, animals and plants, fermentation, bioprocess engineering and bioinformatics. The company is headquartered in Vancouver, Canada. | Corporate Officer/Principal | - | - |
CAVA Healthcare, Inc.
 CAVA Healthcare, Inc. Food: Specialty/CandyConsumer Non-Durables CAVA Healthcare, Inc. operates as a early stage biotechnology company. The company is headquartered in Surrey, Canada. | Président | - | - |
| Directeur Technique/Scientifique/R&D | - | - | |
| Eyam Vaccines & Immunotherapeutics Ltd. | Président | - | - |
| Directeur Technique/Scientifique/R&D | - | - | |
| Fondateur | - | - |
Historique de carrière de Wilfred A. Jefferies
Anciens postes connus de Wilfred A. Jefferies
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| NEVIS BRANDS INC. | Fondateur | 28/01/2011 | - |
| Corporate Officer/Principal | 28/01/2011 | - | |
Synapse Technologies, Inc.
 Synapse Technologies, Inc. Pharmaceuticals: MajorHealth Technology Synapse Technologies Inc. develops an Alzheimer's diagnostic test and potential blood/brain drug delivery mechanism based on the p97 protein. | Fondateur | - | - |
| MARKER THERAPEUTICS, INC. | Président | - | 31/08/2009 |
| Directeur Technique/Scientifique/R&D | - | - |
Formation de Wilfred A. Jefferies
| University of Victoria | Undergraduate Degree |
| Sir William Dunn School of Pathology | Doctorate Degree |
Statistiques
Internationale
| Canada | 8 |
| Etats-Unis | 3 |
| Royaume-Uni | 2 |
Opérationnelle
| Chairman | 4 |
| Chief Tech/Sci/R&D Officer | 4 |
| Founder | 4 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 4 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| MARKER THERAPEUTICS, INC. | Health Technology |
| NEVIS BRANDS INC. | Health Technology |
| MYND LIFE SCIENCES INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Synapse Technologies, Inc.
Synapse Technologies, Inc. Pharmaceuticals: MajorHealth Technology Synapse Technologies Inc. develops an Alzheimer's diagnostic test and potential blood/brain drug delivery mechanism based on the p97 protein. | Health Technology |
Michael Smith Laboratories
Michael Smith Laboratories Miscellaneous Commercial ServicesCommercial Services Michael Smith Laboratories provides biotechnology research and training services. It investigates genetics in human, animals and plants, fermentation, bioprocess engineering and bioinformatics. The company is headquartered in Vancouver, Canada. | Commercial Services |
CAVA Healthcare, Inc.
CAVA Healthcare, Inc. Food: Specialty/CandyConsumer Non-Durables CAVA Healthcare, Inc. operates as a early stage biotechnology company. The company is headquartered in Surrey, Canada. | Consumer Non-Durables |
| Eyam Vaccines & Immunotherapeutics Ltd. |
- Bourse
- Insiders
- Wilfred A. Jefferies
- Expérience
